← All organizations
Highest phase reached
Phase 3
First clinical trial
Apr 25, 2022Last known activity
Oct 20, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 10 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Recent trials (14)
- NCT07223138Lead sponsorPhase 3Oct 20, 2025
- NCT07007637Lead sponsorPhase 3Jun 27, 2025
- NCT06994936Lead sponsorPhase 1Jun 5, 2025
- NCT06768671Lead sponsorPhase 3Dec 30, 2024
- NCT06641089Lead sponsorPhase 3Oct 15, 2024
- NCT06641076Lead sponsorPhase 3Oct 15, 2024
- NCT06411899Lead sponsorPhase 3May 15, 2024
- NCT06411899OfficialPhase 3May 15, 2024
- NCT06411379OfficialPhase 3May 14, 2024
- NCT06411379Lead sponsorPhase 3May 14, 2024
- NCT05640245Study directorPhase 2Dec 31, 2022
- NCT05640245Lead sponsorPhase 2Dec 31, 2022
- NCT05322473Study directorPhase 2Apr 25, 2022
- NCT05322473Lead sponsorPhase 2Apr 25, 2022
Details
- Founded
- Zug, CH
- Last known activity
- Oct 20, 2025